neurological injury News
-
Published Study Demonstrates Kickstart® Effectiveness for Restoring Walking Ability
SEATTLE – Today Cadence Biomedical™, maker of the Kickstart® device, which helps people with neurological conditions recover and walk again, announced its first peer-reviewed publication, “Mobility Training for Patients Recovering from Neurological Injuries with Kickstart®: A Case Series.” The study, published in Physical Medicine and Rehabilitation International, ...
-
STEPS Budapest Center for Robotic Rehabilitation to Install deXtreme 3.1 for Commercial Evaluation
BioXtreme is proud to announce that a new commercial evaluation agreement was signed with STEPS Budapest Center for Robotic Rehabilitation. The agreement includes a 6- months evaluation period for deXtreme, by the end of which STEPS commits to purchasing the device (pending evaluation criteria are met). BioXtreme has developed a ground-breaking robotic device for motor-learning, based on ...
-
BioXtreme and Advanced Medical Solutions s.r.o sign cooperation agreement in Czech Republic and Slovakia
BioXtreme is proud to announce a new cooperation agreement was recently signed with Advanced Medical Solutions s.r.o (AMS) from Brno, Czech Republic. The agreement situates AMS as BioXtreme’s representative in the Czech Republic and Slovakia, with exclusive distribution rights for BioXtreme’s neurorehabilitation products and forming connections with hospitals and rehabilitation ...
-
University Hospitals Leuven & KU Leuven - BioXtreme Joint Clinical Trial Research Project
University Hospitals Leuven, KU Leuven and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the university’s facility in Leuven, Belgium. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological ...
-
FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA). The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory ...
-
Reuth Rehabilitation Hospital - BioXtreme Joint Clinical Trial Research Project
Reuth Rehabilitation Hospital and BioXtreme are proud to announce that they have agreed to conduct a joint clinical trial research project in the hospital’s facility in Tel-Aviv, Israel. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. ...
-
Villa Beretta Rehabilitation Center - BioXtreme Post Marketing Evaluation Site
Villa Beretta Rehabilitation Center and BioXtreme are proud to announce that they have agreed to conduct a joint evaluation project in the hospital’s facility in Costa-Masnaga, Italy. BioXtreme has developed a ground-breaking robotic device for motor-learning, based on innovative error enhancement technology for upper limb rehabilitation from stroke and other neurological injuries. Villa ...
-
New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100) Diagnostic in Neurocritical Care
Data Highlight Daxor’s Diagnostic Changes Care in 69% of Patients With Non-Traumatic Subarachnoid Hemorrhage (nSAH) Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility of the BVA-100 blood test in patients with non-traumatic subarachnoid hemorrhage (nSAH) presented at the virtual ...
-
BIONIK Laboratories to Participate at the American Physical Therapy Association Conference
BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the American Physical Therapy Association (APTA) Conference in San Antonio, Texas from February ...
By Bionik
-
Neurolutions Receives U.S. Food and Drug Administration De Novo Market Authorization for IpsiHand
IpsiHand robotic hand-piece uniquely leverages brain-computer interface technology for chronic stroke rehabilitation IpsiHand also has been granted U.S. FDA Breakthrough Device Designation Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, ...
By Neurolutions
-
BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry
TORONTO & BOSTON--(BUSINESS WIRE)-- BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced its participation in the MEDICA Trade Show in Dusseldorf, Germany from November ...
By Bionik
-
Synaptive Medical Announces Close of $17M Preferred Share Financing
Synaptive Medical, a leader in automation and robotics, announced today it has completed a sale of preferred equity totaling $17,000,000 USD. The investment was made by Sensegain Group, a leading asset management firm in China. Ms. Jing Yang, Board Member & Senior Partner of Sensegain, will join Synaptive’s Board of Directors. Sensegain Group is headquartered in Beijing with multiple ...
-
Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
Case Western Reserve University, in collaboration with NDI Medical LLC, SPR™ Therapeutics, and Valtronic, has been awarded a $3 million grant from the Ohio Third Frontier Commission to commercialize a neurostimulation technology platform designed to treat multiple clinical indications with significant unmet needs, including pain and muscle paralysis. The Ohio Third Frontier Innovation ...
-
MS Clinical Trial starting at East Kent
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with physiotherapists to develop the ...
-
Clinical benefits of exoskeletons
Helena López; why did you decide to become a physiotherapist? Because I like dealing with people, I like helping, I like healthcare… All these reasons were leading me towards medicine, but, in that case, I would spend little time with the patient. I preferred the contact, to be more involved in their evolution. And what made me decide, specifically for the field of neurology, was ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you